(FC) Bioquímica y Genética

2010

1. Corrigendum to "Preliminary characterisation of the promoter of the human p22phox gene: Identification of a new polymorphism associated with hypertension" [FEBS Lett. 542 (2003) 27-31]

   FEBS Letters

2. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

   Leukemia

3. Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein Kinase C: Potential clinical implications in hypertension (Hypertension (2009) 54 (744-750))

   Hypertension

4. Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation

   Leukemia and Lymphoma

5. Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia

   Proceedings of the National Academy of Sciences of the United States of America

6. The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: Potential implication in hypertension (Clinical Science (2009) 116, (233-240))

   Clinical Science